CRA has provided economic assessments of competition in connection with several mergers of clinical laboratories. CRA has analyzed the degree of competition from hospital and physician-owned labs, the nature of bidding for capitated lab arrangements with providers, and the extent to which a national market exists for contracts with health plans exists.
An economic interpretation of Rule 23(b)(3) for antitrust classes
In this article, CRA’s Sean Durkin explains the economic incentives behind class definitions in antitrust cases and why those incentives can lead to classes...